000147405 001__ 147405
000147405 005__ 20240229123023.0
000147405 0247_ $$2doi$$a10.1007/s00259-019-04548-5
000147405 0247_ $$2pmid$$apmid:31673789
000147405 0247_ $$2ISSN$$a0340-6997
000147405 0247_ $$2ISSN$$a1432-105X
000147405 0247_ $$2ISSN$$a1619-7070
000147405 0247_ $$2ISSN$$a1619-7089
000147405 037__ $$aDKFZ-2019-02522
000147405 041__ $$aeng
000147405 082__ $$a610
000147405 1001_ $$aHaupt, Fabian$$b0
000147405 245__ $$a68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol.
000147405 260__ $$aHeidelberg [u.a.]$$bSpringer-Verl.$$c2020
000147405 3367_ $$2DRIVER$$aarticle
000147405 3367_ $$2DataCite$$aOutput Types/Journal article
000147405 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1586867843_11878
000147405 3367_ $$2BibTeX$$aARTICLE
000147405 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000147405 3367_ $$00$$2EndNote$$aJournal Article
000147405 500__ $$a2020 Mar;47(3):624-631
000147405 520__ $$a68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol.
000147405 536__ $$0G:(DE-HGF)POF3-319H$$a319H - Addenda (POF3-319H)$$cPOF3-319H$$fPOF III$$x0
000147405 588__ $$aDataset connected to CrossRef, PubMed,
000147405 7001_ $$aDijkstra, Lotte$$b1
000147405 7001_ $$aAlberts, Ian$$b2
000147405 7001_ $$aSachpekidis, Christos$$b3
000147405 7001_ $$aFech, Viktor$$b4
000147405 7001_ $$aBoxler, Silvan$$b5
000147405 7001_ $$aGross, Tobias$$b6
000147405 7001_ $$0P:(DE-He78)457c042884c901eb0a02c18bb1d30103$$aHolland-Letz, Tim$$b7$$udkfz
000147405 7001_ $$aZacho, Helle D$$b8
000147405 7001_ $$0P:(DE-He78)13a0afba029f5f64dc18b25ef7499558$$aHaberkorn, Uwe$$b9$$udkfz
000147405 7001_ $$aRahbar, Kambiz$$b10
000147405 7001_ $$aRominger, Axel$$b11
000147405 7001_ $$aAfshar-Oromieh, Ali$$b12
000147405 773__ $$0PERI:(DE-600)2098375-X$$a10.1007/s00259-019-04548-5$$n3$$p624-631$$tEuropean journal of nuclear medicine and molecular imaging$$v47$$x1619-7089$$y2020
000147405 909CO $$ooai:inrepo02.dkfz.de:147405$$pVDB
000147405 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)457c042884c901eb0a02c18bb1d30103$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000147405 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)13a0afba029f5f64dc18b25ef7499558$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000147405 9131_ $$0G:(DE-HGF)POF3-319H$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vAddenda$$x0
000147405 9141_ $$y2020
000147405 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000147405 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000147405 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000147405 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000147405 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000147405 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J NUCL MED MOL I : 2017
000147405 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000147405 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000147405 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000147405 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000147405 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000147405 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000147405 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR J NUCL MED MOL I : 2017
000147405 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000147405 9201_ $$0I:(DE-He78)E060-20160331$$kE060$$lE060 KKE Nuklearmedizin$$x1
000147405 980__ $$ajournal
000147405 980__ $$aVDB
000147405 980__ $$aI:(DE-He78)C060-20160331
000147405 980__ $$aI:(DE-He78)E060-20160331
000147405 980__ $$aUNRESTRICTED